The Human Sample Core C will be responsible for: 1) collection and preparation of clinical samples and lung specimens; 2) evaluation of vaccine candidates in human primary epithelial cells; and 3) measuring serum RSV antibodies from human and cotton rat samples. It will support and interact with all 4 Projects and the Animal Core B included in this P01. Thus, this Core will serve two main goals. First, it will assure the quality of the human samples, and it will simplify streamlining sample organization, data management and compliance with all regulations. Second, this core will be responsible for: a) running the in vitro primary cell culture assays to evaluate vaccine candidates generated by Projects 1, 2 and 3; and b) measuring serum RSV antibodies in serum samples obtained from infants included in Project 4 and from experimental infections in cotton rats performed in the Animal Core B. This approach will optimize the use of resources and will facilitate integration and synergy among all projects.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Kim, Sonnie
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Nationwide Children's Hospital
United States
Zip Code
Rodriguez-Fernandez, Rosa; Tapia, Lorena I; Yang, Chin-Fen et al. (2017) Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis. J Infect Dis 217:24-34
Capella, Cristina; Chaiwatpongsakorn, Supranee; Gorrell, Erin et al. (2017) Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection. J Infect Dis 216:1398-1406
Mejias, Asuncion; Garcia-Maurino, Cristina; Rodriguez-Fernandez, Rosa et al. (2017) Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection. Vaccine 35:496-502
Garcia-MauriƱo, Cristina; Moore-Clingenpeel, Melissa; Wallihan, Rebecca et al. (2017) Discharge Criteria for Bronchiolitis: An Unmet Need. Pediatr Infect Dis J :
Battles, Michael B; Langedijk, Johannes P; Furmanova-Hollenstein, Polina et al. (2016) Molecular mechanism of respiratory syncytial virus fusion inhibitors. Nat Chem Biol 12:87-93
Corry, Jacqueline; Johnson, Sara M; Cornwell, Jessica et al. (2016) Preventing Cleavage of the Respiratory Syncytial Virus Attachment Protein in Vero Cells Rescues the Infectivity of Progeny Virus for Primary Human Airway Cultures. J Virol 90:1311-20
Johnson, Sara M; McNally, Beth A; Ioannidis, Ioannis et al. (2015) Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures. PLoS Pathog 11:e1005318
Ngwuta, Joan O; Chen, Man; Modjarrad, Kayvon et al. (2015) Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci Transl Med 7:309ra162